Release Date: 05/09/16 09:53 Summary: Presentation to Institutional Investors-QMN.AX Price Sensitive: No Download Document 3.43MB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling